Abstract-A regression model is developed to predict survival time in months for lung cancer patients. It was previously shown that predictive models perform accurately for short survival times of less than 6 months; however, model accuracy is reduced when attempting to predict longer survival times. This study employs an approach for which regression models are used in combination with a classification model to predict survival time. A set of de-identified lung cancer patient data was obtained from the Surveillance, Epidemiology, and End Results (SEER) database. The models use a subset of factors selected by ANOVA. Model accuracy is measured by a confusion matrix for classification and by Root Mean Square Error (RMSE) for regression. Random Forests are used for classification, while general Linear Regression, Gradient Boosted Machines (GBM), and Random Forests are used for regression. The regression results show that RF had the best performance for survival times ≤6 and >24 months (RMSE 10.52 and 20.51, respectively), while GBM performed best for 7-24 months (RMSE 15.65). Comparison plots of the results further indicate that the regression models perform better for shorter survival times than the RMSE values are able to reflect.
I. INTRODUCTION
Currently, clinicians rely on personal knowledge and experience to estimate survival times of cancer patients. Yet these estimates have been shown to be inaccurate. In [1] , physician consultants predicted a median survival time of 25.7 months, physician registrars predicted a median survival time of 21.4 months, and physician residents predicted a median survival time of 21.5 months for patients with an average of 11.7 months of actual survival. Additionally, for patients that were predicted to live longer than 3 months, only about 60% of them actually survived this long. Another study [2] showed that physicians predicted survival time to the month 10% of the time, within 3 months 59% of the time, and within 4 months 71% of the time. It was shown that short-term survival is overestimated and long-term survival is underestimated.
Machine learning is an appropriate application for this problem because the algorithms can quickly learn from a much larger volume of patients than any set of clinical expertise, which may allow the algorithms to yield more accurate predictions. This problem is important because lung cancer is the leading cause of cancer-related deaths [3] . Cancer patient survival models are generally classification models for either survival or survival time. Classification results may not be as useful as regression for this application since the output of time is continuous and not discrete. Thus, a regression based approach was selected for this study. The data set includes patient variables available at or near the time of diagnosis to represent a proactive set of survival predictors. We previously developed a regression model, but it is limited in that it yielded a large RMSE close to the standard deviation of the dataset [4] . This large RMSE is caused by both overpredictions of patients with lower survival times and the inability of the model to predict beyond 28 months due to the imbalance of training data.
Studies have evaluated lung cancer patient survival by analyzing large data sets, such as from the SEER database, with machine learning techniques, including logistic regression and SVM [5] , and ensemble clustering-based approaches [6] . Data classification techniques were evaluated in [7] to assess the likelihood of patients with particular symptoms to develop lung cancer. A model was developed in [8] for prediction of survival of non-small cell lung cancer (NSCLC) patients by using artificial neural networks (ANNs). Data was used from the National Cancer Institute (NCI) caArray database. Several types of models were produced with different ANN architectures and ultimately yielded an optimal one with an overall accuracy of 83% by classification. In [9] , Naïve-Bayes and Decision Trees were used to predict survival time with lung cancer, achieving an accuracy of 90%. In [10, 11] , an ensemble of five Decision Trees classification models produced the best prediction in terms of the area under the Receiver Operating Characteristic (ROC) curve. In [12] , an association rule technique was used to create a tree of rules for lung cancer. Association rule mining techniques were used to determine correlation or association relationships among the data. Different standard criteria and techniques to extract the rules were proposed in [13] . The effectiveness of lung cancer treatment was considered in [14] . Other work analyzing the SEER database focusing on lung cancer via statistical and classification techniques have included [15] [16] [17] [18] [19] [20] [21] [22] and [23] [24] [25] , respectively, and has been reviewed in [26] . Recently, unsupervised methods were shown to yield comparable results to supervised techniques [27] .
With respect to cancers other than lung, a study by [28] used a classification approach to predict survival at 6, 12, and 24 months. Models were developed using data from the Evaluation of Cancer Outcomes (ECO) registry, from electronic administrative records (EARs), or from both. An ensemble approach with 400 SVM with linear kernel (averaged output) was used for each model. The model using both sets of data performed best for genitourinary, head and neck, lung, skin, and upper gastrointestinal tumors. A study by [29] used artificial neural networks, Decision Trees, SVM, and logistic regression to predict prostate cancer survivability. SVM had the best test set accuracy (92.85%). Prostate cancer survivability was evaluated in a similar study [30] using the same models. Colon cancer patient data from the SEER database was used in [31] to predict patient survival, finding that neural networks were the most accurate. In a study by [32] , an ensemble of the three best performing classifiers resulted in the best prediction for colon cancer survival according to the area under the ROC curve. A probabilistic model using Bayesian network (BN) was used to predict the short survivability of patients with brain metastasis from lung cancer [33] .
Models have also been developed to predict survival of patients diagnosed with breast cancer, including Support Vector Machine (SVM), ANN, and semisupervised methods (as reviewed in [26] and associated references). In early work, the concept of agglomerative clustering was applied to assemble groups of cancer patients [34] . A rule-based classification method was used in [35] to predict different types of breast cancer survival, showing that Trees Random Forest (TRF) had better results. Artificial neural networks, Decision Trees, and logistic regression were used in [36] to predict breast cancer survivability with accuracies of 93.6% 89.2%, respectively.
In this study, patients diagnosed with lung cancer during the years 2004-2009 were selected from deidentified information provided in the SEER database in order to predict their survival time. The SEER Program is an authoritative repository of cancer statistics in the United States [37] . Classification modeling was used to broadly separate validation data into three categories of survival time: less than or equal to 6 months, 7-24 months, and greater than 24 months. Each of these categories had its own respective regression model, with the goal to predict a more precise survival time for the validation data. The chosen algorithm for classification was Random Forests, and the chosen algorithms for regression included Random Forests, General Linear Regression, and Gradient Boosted Machines.
II. METHODS

A. Data Analysis
The patient data was first analyzed using Minitab. Next, an ANOVA was performed with survival time as the response and with 24 input parameters to select significant model parameters and to reduce dimensionality. Prior to analysis, outlier data (only one instance of a parameter level) were removed. The analysis was performed ensuring that parameters were appropriately coded as either numeric or non-numeric. For the ANOVA, a two-sided 95% confidence interval and adjusted (Type III) sum of squares for tests were used. A box-cox transformation was used with optimal λ in Minitab to improve the linearity of the normal probability plot. In order to perform the box-cox transformation, the survival times of 0 had to be replaced with 0.5. This replacement value was chosen since those data points represent less than 1-month survival. Out of the 24 parameters, 15 were determined to be significant (p-value<0.05). Parameters were not selected if they could not be known or estimated at the time of diagnosis or if they could not be estimated by ANOVA. Two of the significant parameters were not selected because they could not be known at the time of diagnosis due to being classifiers for cause of death. Parameters not selected were CODtositerecode, which includes classifiers for all cancer-related and cancerunrelated causes of death, and SEERcause.specificdeathclassification. which includes classifiers that describe whether the cause of death was due to cancer. AgeNumeric, GradeNumeric, StageNumeric, and TNumeric. Definitions are described in the SEER database documentation [38] .
B. Model Design
The next step was to design the predictive model. Random sampling was used to select 75% of the data for training and the rest for validation. The first step was a classification-based model which separates the validation data into three separate categories: less than or equal to 6 months survival, 7-24 months survival, and greater than 24 months survival. This categorical split was selected to improve regression predictions for low and high survival times. This classification model was trained with all training data. Next, three regression models were made for each category, each using the same algorithms and parameters, but trained with a different portion of the data. The first category used data from 0-12 months, the second category was trained with all training data, and the third category was trained with data greater than or equal to 18 months. A wider range of data was used for training of each regression model to be able to predict data within or slightly outside the intended range. All data was used for training the second category since it was the largest category and contained data across the entire range of the data set.
The classification model used Random Forests (RF) while the regression models used General Linear Regression (GL), RF, Gradient Boosted Machines (GBM), and a custom ensemble. RF were selected for classification and regression since they performed well in the classification models in literature. GL was selected as it is the simplest regression model and performs well with the data set. GBM was selected because it is similar to RF, but the model is built progressively in stages instead of all at once. RF was used over GBM for classification because it performed this task slightly better.
C. Classification, Random Forests
An arbitrary tree count of 1000 was selected; increasing the count beyond this count did not increase accuracy. The "mtry" parameter was 3, which is the constraint for the number of variables randomly sampled as candidates at each split since it improved accuracy over the default (the default value for classification is the square root of parameters). 50 was selected for the node size (minimum size of terminal nodes) to produce smaller trees (the default value for classification is 1) which are less precise but less prone to outlier data. Importance of predictors was assessed. HistologicTypeICD.O.3 could not be used for training due to the high number of classifiers. A conditional inference random forest model was considered to handle the higher number of classifiers for HistologicTypeICD.O.3; however, it was ultimately rejected due to producing poorer results since a much smaller tree count was necessary for the model to converge. The "randomForest" package was used in R.
D. Regression, Random Forests
For the regression model, 500 trees were used with 10-fold cross validation. Increasing the tree count did not improve model accuracy. 50 was selected for the node size as in the other RF model (the default value for regression is 5). The 10-fold cross validation was also used to select between three possible values for the "mtry" parameter: 3, 5, 7 (the default for regression is one third of the number of parameters) in order to select the best possible parameter value. The "randomForest" package was used in R.
E. Regression, Gradient Boosted Machines
Similar to the RF model, 500 trees were used with 10-fold cross validation. 50 was selected for the node size as in the RF models. 1 was selected for the interaction depth (additive model without interaction). 0.1 was selected for the shrinkage, which is also known as the learning rate. The "gbm" package was used in R.
F. Regression, General Linear Regression
No unique parameters were used for the general linear model. The "glm" training method was used in R.
G. Regression, Custom Ensemble
The custom ensemble is a simple linear model of the other regression models (RF, GBM, and GL) where each model's predictions are weighted differently. The weights are determined by a linear regression with each individual model's predictions of the training data survival times and the actual training data survival times.
III. RESULTS
The classification results in Table II indicate an overall accuracy of 50.3% and an error rate of 49.7%. Sensitivity was 31%, 76.4%, and 24.4% for Classes 1, 2, and 3, respectively, while precision was essentially 50% for all classes. This performance reflects the fact that these measures may not be the best to evaluate classification models, especially with unbalanced data. Further, the classification model is over-fitted on class 2, which is the class of 7-24 months with the bulk of the training data (46.8% of the actual data is in class 2). For the regression model (≤6 months), RF showed the best performance (Table IV) . All the models primarily predicted within the range of roughly 3-7 months, and under-predicted large survival times (Fig. 1) . In all figures, model predictions are on the x axis and actual survival times are on the y axis. For 7-24 months, GBM had the best RMSE (Table  V) , although RF performed better (Fig. 2) . For time >24 months, RF had the best RMSE (Table  VI) even though GBM performed better (Fig. 3) . 
IV. DISCUSSION
The goal of this study was to explore the possibility of more accurately predicting lung cancer patient survival by using a classification model along with three regression models. The purpose of the classification stage was to separate the validation data into smaller categories (survival ≤6, 7-24, or >24 months). Then, a regression model specific to each category could attempt to predict a more specific survival time. As expected, for the regression models, the predictions were more accurate when the actual survival time was lower. RMSE was used to measure accuracy because it is a common measurement of accuracy for regression models; however, it is misleading when trying to understand how well the models actually perform. Because of how RMSE is calculated, larger errors affect the value much more than smaller errors. This leads to a much larger apparent RMSE when predicting low survival times, such as in the first category (≤6 months), due to the wide range of data present. The comparison plots show that the regression models perform better for lower survival times, but the RMSE values do not properly represent the difference in performance.
Several different approaches were attempted when initially designing the models to address two specific issues: not being able to predict outside a narrow range and having a large RMSE. The first approach was to oversample data beyond 28 months for training and validating; however, this only allowed the models to predict slightly further. The oversampling approach was not used because it leads to an overall lower RMSE and could lead to further overfitting to the data set. The second approach was to remove data beyond 28 months for training and validating. This led to a much lower RMSE (~7 months), but introduced a similar issue of not being able to predict beyond approximately 15 months. The next approach was to create a random forest classification model using the original survival time classifiers assigned by the SEER database: C0, C1, C2, C3, C4, C5. With these classifiers, each number represents the survival time year threshold exceeded. This classification model would not predict any data points other than C0 or C1 due to the imbalance of the data set.
In the approach that was implemented, the classification model directly affects the regression model accuracy. The classification model could be improved by choosing a different set of classes. The models used in this study are prone to overfitting, so each class should contain approximately the same amount of data. The current design is able to predict a wider range of survival times with varying RMSE values. The most ideal regression models were for the range of ≤6 months, which had both a more linear plot and a lower RMSE. There are likely two reasons for this: there is more data for lower survival times, and lower survival times are more predictable. For our previous design in [4] , the GBM model achieved the highest single-model RMSE of 15.32. The best RMSE value achieved in the design outlined in this study was 10.52 by the RF model. Although both RMSE values are inflated by large errors due to the range of the data, the result here improve upon the previous study.
In conclusion, predictive models can perform accurately with lung cancer patient data in the SEER database for short survival times of ≤6 months; however, the accuracy is reduced as the models attempt to predict higher survival times. A primary limiting factor is that the range of data is too wide. This may be a problem because not all patient deaths are due to cancer, especially for longer survival times, Although regression models have potential for more accurately predicting short term survival, more work is necessary to improve and validate such methods for meaningful clinical application.
